Inequalities in time to diagnosis of Down Syndrome in Bolivia

Daniel Linares Terrazas Physician. Research Assistant, Cytogenetics Unit, Institute of Genetics, Universidad Mayor de San Andrés, La Paz, Bolivia. image/svg+xml , Beatriz Luna Barrón Physician. Research Professor, Institute of Genetics, Universidad Mayor de San Andrés, La Paz, Bolivia. image/svg+xml , Gonzalo Taboada López Médico. Docente investigador, Instituto de Genética, Universidad Mayor de San Andrés, La Paz, Bolivia. image/svg+xml
Received: 28 October 2023, Accepted: 28 February 2024, Published: 19 March 2024 Open Access
Abstract views
603
Metrics Loading ...

Abstract


Down Syndrome is the most common genetic condition and a leading cause of intellectual disability. Individuals in rural areas, particularly those with disabilities, often face disparities in healthcare access. Analyzing clinical records of patients diagnosed with Down Syndrome between 2013 and 2022 by the Institute of Genetics at the Universidad Mayor de San Andrés in La Paz, Bolivia, this study examined the time to diagnosis for 250 patients with Down Syndrome. The findings revealed that patients from rural areas with Down Syndrome take an average of five months to receive a diagnosis, compared to two months in urban areas (p<0.001). No significant differences were found in the time to diagnosis based on gender. However, a higher proportion of males from rural areas was observed (p=0.03). The results suggest that individuals in rural areas face challenges in receiving a timely diagnosis. On the other hand, women may not be brought to cities for proper diagnosis and treatment due to gender biases in certain communities. The importance of improving access to early diagnosis and treatment in rural areas is emphasized.

Full-text of the article is available for this language: Español.


References


1. Bull MJ. Down Syndrome. New England Journal of Medicine. 2020;382(24):2344–2352.
Crossref | PubMed

2. Guralnick MJ. Why early intervention works: A systems perspective. Infants and Young Children. 2011;24(1):6-28.
Crossref | PubMed

3. Guralnick MJ. Early Intervention approaches to enhance the peer-related social competence of young children with developmental delays: A historical perspective. Infants and Young Children. 2010;23(2):73-83.
Crossref | PubMed

4. Seager E, Sampson S, Sin J, Pagnamenta E, Stojanovik V. A systematic review of speech, language and communication interventions for children with Down syndrome from 0 to 6 years. International Journal of Language & Communication Disorders. 2022;57(2):441-463.
Crossref | PubMed

5. Piatti AE, Stefani B, Bini G, Bargagna S. Multidisciplinary early intervention in Down syndrome: a retrospective study. Minerva Pediatrics. 2022.
Crossref | PubMed

6. Diniz NLF, Parlato-Oliveira E, Pimenta PGA, Araújo LA de, Valadares ER. Autism and Down syndrome: early identification and diagnosis. Arquivos de Neuro-Psiquiatria. 2022;80(6):620-630.
Crossref | PubMed

7. Starfield B. The hidden inequity in health care. International Journal for Equity in Health. 2011;10:15.
Crossref | PubMed

8. Arcaya MC, Arcaya AL, Subramanian SV. Inequalities in health: definitions, concepts, and theories. Global Health Action. 2015;8:27106.
Crossref | PubMed

9. Singh GK, Siahpush M. Widening rural-urban disparities in life expectancy, U.S., 1969-2009. American Journal of Preventive Medicine. 2014;46(2):e19-29.
Crossref | PubMed

10. Krnjacki L, Emerson E, Llewellyn G, Kavanagh AM. Prevalence and risk of violence against people with and without disabilities: findings from an Australian population-based study. Australian and New Zealand Journal of Public Health. 2016;40(1):16-21.
Crossref | PubMed

11. Dammeyer J, Chapman M. A national survey on violence and discrimination among people with disabilities. BMC Public Health. 2018;18(1):355.
Crossref | PubMed

12. Matin BK, Williamson HJ, Karyani AK, Rezaei S, Soofi M, Soltani S. Barriers in access to healthcare for women with disabilities: a systematic review in qualitative studies. BMC Women’s Health. 2021;21(1):44.
Crossref | PubMed

13. Emerson E, Llewellyn G. Exposure of women with and without disabilities to violence and discrimination: evidence from cross-sectional national surveys in 29 middle- and low-income countries. Journal of Interpersonal Violence. 2023;38(11–12):7215-7241.
Crossref | PubMed

14. García-Domingo M, Fuentes V, De La Fuente Robles YM, Muyor J. Disability policies and management in Bolivia: Changes and challenges. Journal of Disability Policy Studies. 2022;33(1):55-65.
Crossref

15. Bachfischer A, Barbosa MC, Rojas AAR, Bechler R, Schwienhorst-Stich EM, Kasang C, et al. Implementing community based inclusive development for people with disability in Latin America: a mixed methods perspective on prioritized needs and lessons learned. International Journal for Equity in Health. 2023;22(1):147.
Crossref | PubMed

16. Díaz-Aristizabal U, Sanz-Victoria S, Sahonero-Daza M, Ledesma-Ocampo S, Cachimuel-Vinueza M, Torrico M. Reflexiones sobre la estrategia de rehabilitación basada en la comunidad (RBC): la experiencia de un programa de RBC en Bolivia. Ciência & Saúde Coletiva. 2012;17:167-177.
Crossref | PubMed

17. Emerson E, Spencer N. Chapter two - health inequity and children with intellectual disabilities. In: Hatton C, Emerson E, (eds.). International review of research in developmental disabilities. Elsevier; 2015. p. 11–42. 10.1016/bs.irrdd.2015.03.001.
Crossref

18. McGlinchey E, Iulita MF, Fortea J. Compounded inequality: racial disparity and Down syndrome. The Lancet Public Health. 2023;8(11):e836.
Crossref | PubMed

19. Omorodion J, Dowsett L, Clark R, Fraser J, Abu-El-Haija A, Strong A, et al. Delayed diagnosis and racial bias in children with genetic conditions. American Journal of Medical Genetics, Part A. 2022;188(4):1118–1123.
Crossref | PubMed

20. Pettan-Brewer C, Martins AF, Abreu DPB de, Brandão APD, Barbosa DS, Figueroa DP, et al. From the approach to the concept: one health in Latin America, experiences and perspectives in Brazil, Chile, and Colombia. Frontiers in Public Health. 2021;9:687110.
Crossref | PubMed

21. Strasser R. Rural health around the world: challenges and solutions. Family Practice. 2003;20(4):457-463.
Crossref | PubMed

22. Neille J, Penn C. Beyond physical access: a qualitative analysis into the barriers to policy implementation and service provision experienced by persons with disabilities living in a rural context. Rural and Remote Health. 2015;15(3):3332.
Crossref

23. Filipe MG, Cruz S, Veloso AS, Frota S. Early predictors of language outcomes in Down syndrome: A mini-review. Frontiers in Psychology. 2022;13:934490.
Crossref | PubMed

24. Kucik JE, Shin M, Siffel C, Marengo L, Correa A, for the Congenital Anomaly Multistate Prevalence and Survival Collaborative. Trends in survival among children with Down Syndrome in 10 regions of the United States. Pediatrics. 2013;131(1):e27–e36.
Crossref | PubMed

25. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Research Part A: Clinical and Molecular Teratology. 2010;88(12):1008-1016.
Crossref | PubMed

26. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down’s syndrome in the USA from 1983 to 1997: a population-based study. The Lancet. 2002;359(9311):1019-1025.
Crossref | PubMed

27. Kabia E, Mbau R, Muraya KW, Morgan R, Molyneux S, Barasa E. How do gender and disability influence the ability of the poor to benefit from pro-poor health financing policies in Kenya? An intersectional analysis. International Journal for Equity in Health. 2018;17(1): 149.
Crossref | PubMed

28. Caraballo C, Massey DS, Ndumele CD, Haywood T, Kaleem S, King T, et al. Excess mortality and years of potential life lost among the black population in the US, 1999-2020. JAMA. 2023;329(19):1662-1670.
Crossref | PubMed

29. Puyana A. Horizontal inequality and ethnic discrimination in four Latin American countries. CEPAL Review. 2018;125:45-67.
Crossref

30. O’Connor C. Karyotyoing for chromosomal abnormalities. Nature Education. 2008;1(1):27.

31. Hodapp RM. Families of persons with Down syndrome: new perspectives, findings, and research and service needs. Mental Retardation and Developmental Disabilities Research Reviews. 2007;13(3):279-287.
Crossref | PubMed

32. Piotrkowska R, Terech-Skóra S, Mędrzycka-Dąbrowska W, Jarzynkowski P, Król M. Factors determining acceptance of disease and its impact on satisfaction with life of patients with peripheral artery disease. Nursing Open. 2021;8(3):1417-1423.
Crossref | PubMed

33. Pluta A, Sulikowska B, Manitius J, Posieczek Z, Marzec A, Morisky DE. Acceptance of illness and compliance with therapeutic recommendations in patients with hypertension. International Journal of Environmental Research and Public Health. 2020;17(18):6789.
Crossref | PubMed

34. Amr NH. Thyroid disorders in subjects with Down syndrome: an update. Acta BioMedica. 2018;89(1):132-139.

35. Dimopoulos K, Constantine A, Clift P, Condliffe R, Moledina S, Jansen K, et al. Cardiovascular complications of Down syndrome: Scoping review and expert consensus. circulation. 2023;147(5):425-441.
Crossref | PubMed

36. Luna Barrón B, Taboada López G, Queiroz de Tejerina MS, Aillón López V, Arce Quint I, Barreda Luján EM, et al. Comorbilidades en personas con síndrome de Down, habitantes de La Paz - Bolivia, 2015. Revista Médica La Paz. 2017;23(1):5-11.
Crossref

37. Santoro SL, Steffensen EH. Congenital heart disease in Down syndrome – A review of temporal changes. Journal of Congenital Cardiology. 2021;5(1):1.
Crossref

38. van Trotsenburg P, Stoupa A, Léger J, Rohrer T, Peters C, Fugazzola L, et al. Congenital hypothyroidism: A 2020–2021 consensus guidelines update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid. 2021;31(3):387-419.
Crossref | PubMed